Vaxtex Cotfab Limited Logo

Vaxtex Cotfab Limited

VCL.NS

(1.5)
Stock Price

0,82 INR

-18.68% ROA

-32.29% ROE

-1.67x PER

Market Cap.

152.514.334,00 INR

61.29% DER

0% Yield

-157.83% NPM

Vaxtex Cotfab Limited Stock Analysis

Vaxtex Cotfab Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Vaxtex Cotfab Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

ROE in an average range (6.94%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (1.227), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

5 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Vaxtex Cotfab Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Vaxtex Cotfab Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Vaxtex Cotfab Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Vaxtex Cotfab Limited Revenue
Year Revenue Growth
2015 6.257.000
2016 44.270.000 85.87%
2017 184.663.000 76.03%
2018 219.727.000 15.96%
2019 277.580.035 20.84%
2020 261.544.582 -6.13%
2021 619.073.695 57.75%
2022 756.215.000 18.14%
2023 435.616.000 -73.6%
2023 166.203.000 -162.1%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Vaxtex Cotfab Limited Research and Development Expenses
Year Research and Development Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Vaxtex Cotfab Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 177.000 100%
2017 111.000 -59.46%
2018 291.000 61.86%
2019 5.499.964 94.71%
2020 6.494.397 15.31%
2021 729.123 -790.71%
2022 12.977.000 94.38%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Vaxtex Cotfab Limited EBITDA
Year EBITDA Growth
2015 284.000
2016 501.000 43.31%
2017 3.764.000 86.69%
2018 9.841.000 61.75%
2019 12.951.343 24.02%
2020 14.801.375 12.5%
2021 33.710.619 56.09%
2022 5.114.000 -559.18%
2023 23.641.000 78.37%
2023 -91.415.000 125.86%
2024 3.376.000 2807.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Vaxtex Cotfab Limited Gross Profit
Year Gross Profit Growth
2015 559.000
2016 2.952.000 81.06%
2017 50.811.000 94.19%
2018 75.475.000 32.68%
2019 32.005.550 -135.82%
2020 26.914.356 -18.92%
2021 77.763.671 65.39%
2022 53.062.000 -46.55%
2023 28.692.000 -84.94%
2023 -55.128.000 152.05%
2024 -592.000 -9212.16%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Vaxtex Cotfab Limited Net Profit
Year Net Profit Growth
2015 78.000
2016 185.000 57.84%
2017 1.709.000 89.17%
2018 6.020.000 71.61%
2019 932.055 -545.88%
2020 1.783.113 47.73%
2021 14.859.000 88%
2022 11.320.000 -31.26%
2023 14.956.000 24.31%
2023 -88.340.000 116.93%
2024 3.120.000 2931.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Vaxtex Cotfab Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Vaxtex Cotfab Limited Free Cashflow
Year Free Cashflow Growth
2015 1.303.000
2016 -37.828.000 103.44%
2017 681.000 5654.77%
2018 15.052.000 95.48%
2019 -81.058.372 118.57%
2020 -6.899.050 -1074.92%
2021 18.155.115 138%
2022 -118.792.000 115.28%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Vaxtex Cotfab Limited Operating Cashflow
Year Operating Cashflow Growth
2015 1.303.000
2016 -34.094.000 103.82%
2017 15.086.000 326%
2018 17.170.000 12.14%
2019 -73.935.813 123.22%
2020 9.315.879 893.65%
2021 21.734.695 57.14%
2022 -118.561.000 118.33%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Vaxtex Cotfab Limited Capital Expenditure
Year Capital Expenditure Growth
2015 0
2016 3.734.000 100%
2017 14.405.000 74.08%
2018 2.118.000 -580.12%
2019 7.122.559 70.26%
2020 16.214.929 56.07%
2021 3.579.580 -352.98%
2022 231.000 -1449.6%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Vaxtex Cotfab Limited Equity
Year Equity Growth
2015 39.371.000
2016 39.555.000 0.47%
2017 41.264.000 4.14%
2018 47.284.000 12.73%
2019 86.519.967 45.35%
2020 88.735.594 2.5%
2021 103.593.187 14.34%
2022 234.823.000 55.88%
2023 187.905.000 -24.97%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Vaxtex Cotfab Limited Assets
Year Assets Growth
2015 41.931.000
2016 47.000.000 10.79%
2017 101.876.000 53.87%
2018 135.029.000 24.55%
2019 279.240.249 51.64%
2020 216.860.311 -28.77%
2021 239.882.508 9.6%
2022 694.847.000 65.48%
2023 488.717.000 -42.18%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Vaxtex Cotfab Limited Liabilities
Year Liabilities Growth
2015 2.560.000
2016 7.445.000 65.61%
2017 60.612.000 87.72%
2018 87.745.000 30.92%
2019 192.720.282 54.47%
2020 128.124.717 -50.42%
2021 136.289.321 5.99%
2022 460.024.000 70.37%
2023 300.811.000 -52.93%

Vaxtex Cotfab Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.31
Net Income per Share
-0.5
Price to Earning Ratio
-1.67x
Price To Sales Ratio
2.64x
POCF Ratio
51.46
PFCF Ratio
51.46
Price to Book Ratio
0.81
EV to Sales
4.62
EV Over EBITDA
-2.79
EV to Operating CashFlow
90.24
EV to FreeCashFlow
90.24
Earnings Yield
-0.6
FreeCashFlow Yield
0.02
Market Cap
0,15 Bil.
Enterprise Value
0,27 Bil.
Graham Number
3.38
Graham NetNet
-0.59

Income Statement Metrics

Net Income per Share
-0.5
Income Quality
-0.03
ROE
-0.32
Return On Assets
-0.19
Return On Capital Employed
-0.33
Net Income per EBT
0.99
EBT Per Ebit
0.96
Ebit per Revenue
-1.68
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-1.05
Operating Profit Margin
-1.68
Pretax Profit Margin
-1.6
Net Profit Margin
-1.58

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.02
Free CashFlow per Share
0.02
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.32
Return on Tangible Assets
-0.19
Days Sales Outstanding
1513.69
Days Payables Outstanding
540.92
Days of Inventory on Hand
6.6
Receivables Turnover
0.24
Payables Turnover
0.67
Inventory Turnover
55.33
Capex per Share
0

Balance Sheet

Cash per Share
0,06
Book Value per Share
1,02
Tangible Book Value per Share
1.02
Shareholders Equity per Share
1.02
Interest Debt per Share
0.63
Debt to Equity
0.61
Debt to Assets
0.24
Net Debt to EBITDA
-1.2
Current Ratio
2.11
Tangible Asset Value
0,19 Bil.
Net Current Asset Value
0,12 Bil.
Invested Capital
231406000
Working Capital
0,22 Bil.
Intangibles to Total Assets
0
Average Receivables
0,12 Bil.
Average Payables
0,09 Bil.
Average Inventory
1073000
Debt to Market Cap
0.76

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Vaxtex Cotfab Limited Dividends
Year Dividends Growth

Vaxtex Cotfab Limited Profile

About Vaxtex Cotfab Limited

Vaxtex Cotfab Limited manufactures textiles. The company offers denim fabrics, home textile, jeans, men's casual shirts, printed fabrics, and yarns. It offers shirting fabrics to various international brands, export houses, corporate buyers, domestic traders, wholesalers, and distributors. The company was incorporated in 2005 and is based in Ahmedabad, India.

CEO
Mr. Mithleshkumar Mulchand Aga
Employee
36
Address
Survey No. 230, Opp. Mariya Park
Ahmedabad, 382405

Vaxtex Cotfab Limited Executives & BODs

Vaxtex Cotfab Limited Executives & BODs
# Name Age
1 Mr. Mithleshkumar Mulchand Agarwal
MD & Executive Director
70
2 Mr. Pratapsingh Bhoorsingh Zala
Chief Financial Officer
70

Vaxtex Cotfab Limited Competitors